Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
Clinical trial NCT06810050 · COMPLETED
Trial details
- NCT number
- NCT06810050
- Sponsor
- CAGE Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2025-08-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.